First-on-Podium Data from 20 Vascular and Venous Clinical Trials to Be Presented at The VEINS and VIVA 2023

/PRNewswire/ -- Leading physicians and researchers will present results from 20 clinical trials from Monday, October 30, to Wednesday, November 1, at the...

Related Keywords

Sakura ,Kochi ,Japan ,Japanese ,Erica Secemsky ,Seanp Lyden ,Wynn Las Vegas ,Raghu Kolluri ,D Christopher Metzger ,Nicolas Shammas ,Daniel Clair ,Robert Lookstein ,Anvar Babaev ,Williama Gray ,Marianne Brodmann ,Thomas Zeller ,Ido Weinberg ,Mahmood Razavi ,Davidj Dexter ,Osamu Iida ,Roberte Beasley ,Jay Mathews , ,Wynn Las ,Vascular Interventional Advances ,Venous Endovascular ,Year Clinical Outcomes ,Stent System ,Akura Medical Thrombectomy System ,Treating Venous ,Augment Deep Vein Thrombosis Intervention ,Month Results From ,Open Label Phase ,Non Invasive Therapeutic Ultrasound ,Increase Perfusion ,Chronic Limb Threatening Ischemia ,Year Results ,Bare Temporary Spur Stent System ,Combination With ,Year Outcomes ,Complex Femoropopliteal Lesions ,Controlled Trial Evaluating ,Drug Eluting Resorbable ,Month Results ,Orbital Atherectomy ,Femoropopliteal Artery Lesions ,Restenosis Rates ,Multicenter Trial Evaluation ,Day Outcomes ,Data From ,Day Results From ,C Guardians Pivotal Trial ,Carotid Stent ,Vasculare Registry ,Gender Subgroup ,Patients With Chronic Limb Threatening ,Day Functional Outcomes ,Interim Analysis ,Month Outcomes ,Subgroup Analysis ,Pooled Analysis ,